UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 01/2016, Volume 87, Issue 1, pp. 93 - 99
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Reproducibility of Results | Age Factors | Follow-Up Studies | Area Under Curve | Humans | Middle Aged | Male | Evidence-Based Medicine | Multiple Sclerosis - epidemiology | Multiple Sclerosis - therapy | Disease Progression | Atrophy | Young Adult | Magnetic Resonance Imaging | Reference Standards | Brain - pathology | Multiple Sclerosis - pathology | Adult | Female | ROC Curve | Longitudinal Studies | Multiple sclerosis | Usage | Brain research | Research | Magnetic resonance imaging | Studies | Quality control | Clinical trials | Physiology | Patients | Methods | Index Medicus | Multiple Sclerosis | MRI | 1506
Journal Article
Lancet neurology, ISSN 1474-4422, 2013, Volume 12, Issue 7, pp. 669 - 676
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Multiple Sclerosis, Relapsing-Remitting - pathology | Recurrence | Data Interpretation, Statistical | Follow-Up Studies | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Linear Models | Treatment Outcome | Randomized Controlled Trials as Topic | Magnetic Resonance Imaging | Algorithms | Image Processing, Computer-Assisted | Endpoint Determination | Biomarkers | Adult | Multiple sclerosis | Relapse | Magnetic resonance imaging | Analysis | Diseases | Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 06/2020, Volume 19, Issue 6, pp. 481 - 482
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Pandemics | Coronavirus Infections - diagnosis | Pneumonia, Viral - therapy | Humans | Multiple Sclerosis - virology | Multiple Sclerosis - therapy | COVID-19 | SARS-CoV-2 | Coronavirus Infections - therapy | Pneumonia, Viral - complications | Betacoronavirus | Coronavirus Infections - complications | Pneumonia, Viral - diagnosis | Italy | Pneumonia | Multiple sclerosis | Disease | Data collection | Septic shock | Infections | Coronaviruses | Patients | Immunosuppressive agents | Index Medicus
Journal Article
EMBO molecular medicine, ISSN 1757-4676, 12/2015, Volume 7, Issue 12, pp. 1513 - 1528
dystrophin | MRI | cell therapy | Duchenne | mesoangioblast | Cell therapy | Dystrophin | Mesoangioblast | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Infusions, Intra-Arterial - statistics & numerical data | Cell- and Tissue-Based Therapy | Muscular Dystrophy, Duchenne - therapy | Histocompatibility Testing | Humans | Muscular Dystrophy, Duchenne - surgery | Stroke (Disease) | Tacrolimus | Analysis | Immunotherapy | Utrophin | Development and progression | Muscular dystrophy | Stroke | Medical imaging | Disease | Transplantation | Patients | Arteries | Immunosuppressive agents | Studies | Ultrasonic imaging | Magnetic resonance imaging | Biopsy | Cardiac function | Duchenne's muscular dystrophy | Stem cells | Thalamus | Histocompatibility antigen HLA | Mutation | Age | Veins & arteries | Index Medicus | s | Genetics, Gene Therapy & Genetic Disease | Musculoskeletal System
Journal Article
5.
Full Text
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
Multiple sclerosis, ISSN 1352-4585, 2/2018, Volume 24, Issue 2, pp. 96 - 120
GRADE methodology | Multiple sclerosis | disease-modifying therapies | guideline | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Evidence-Based Medicine - standards | Immunomodulation | Practice Guidelines as Topic - standards | Humans | Immunologic Factors - administration & dosage | Consensus | Multiple Sclerosis - drug therapy | Pregnancy | Experimental allergic neuritis | Index Medicus | Medicin och hälsovetenskap
Journal Article
6.
Full Text
Real-world studies provide reliable comparisons of disease modifying therapies in MS – No
Multiple sclerosis, ISSN 1352-4585, 2/2020, Volume 26, Issue 2, pp. 161 - 162
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Observational Studies as Topic | Comparative Effectiveness Research | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Immunologic Factors - therapeutic use | Randomized Controlled Trials as Topic | Index Medicus
Journal Article
Annals of neurology, ISSN 0364-5134, 02/2016, Volume 79, Issue 2, pp. 288 - 294
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Multiple Sclerosis, Relapsing-Remitting - pathology | Age Factors | Follow-Up Studies | Humans | Middle Aged | Multiple Sclerosis, Chronic Progressive - pathology | Demyelinating Diseases - epidemiology | Male | Multiple Sclerosis, Relapsing-Remitting - diagnosis | Multiple Sclerosis, Chronic Progressive - epidemiology | Disease Progression | Young Adult | Magnetic Resonance Imaging | Demyelinating Diseases - diagnosis | Multiple Sclerosis, Chronic Progressive - diagnosis | Adolescent | Multiple Sclerosis, Relapsing-Remitting - epidemiology | Sex Factors | Adult | Female | Demyelinating Diseases - pathology | Child | Spinal cord | Demographics | Multiple sclerosis | Populations | Magnetic resonance imaging | Rope | Men | Evolution | Standard deviation | Lesions | Age | Geriatrics | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 05/2019, Volume 92, Issue 22, pp. e2538 - e2549
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Multiple Sclerosis, Relapsing-Remitting - therapy | Humans | Adolescent | Clinical Trials as Topic - ethics | Clinical Trials as Topic - methods | Evidence-Based Medicine | Child | Index Medicus | Abridged Index Medicus | 227
Journal Article
Annals of neurology, ISSN 0364-5134, 01/2014, Volume 75, Issue 1, pp. 43 - 49
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Multiple Sclerosis, Relapsing-Remitting - therapy | Humans | Atrophy - pathology | Multiple Sclerosis, Relapsing-Remitting - epidemiology | Brain - pathology | Treatment Outcome | Multiple Sclerosis, Relapsing-Remitting - diagnosis | Randomized Controlled Trials as Topic - trends | Disabled Persons | Disease Progression | Drug therapy | Brain | Nuclear magnetic resonance--NMR | Index Medicus
Journal Article